HR

Healthcare Realty Trust Incorporated

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-28.6M
ExitQ1 2026
$29M
--
$20.20
Jim SimonsRenaissance Technologies
$26M1.5M shares
AddQ1 2026
$13M
$16.99
$20.20
Steven CohenPoint72
$329k19.4k shares
TrimQ1 2026
$6.6M
$16.99
$20.20
Jefferies GroupInvestor
$1.3M76.6k shares
AddQ1 2026
$692k
$16.99
$20.20
Richard PzenaPzena Investment Management
$38M2.2M shares
AddQ1 2026
$83k
$16.99
$20.20
Ken GriffinCitadel Advisors
$29M1.7M shares
ExitQ4 2025
$39M
$16.95
$20.20

News

zacks.comNew Strong Buy Stocks for June 8thzacks.comJun 8gurufocus.comCamizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6gurufocus.comJun 2gurufocus.comIvonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONgurufocus.comMay 31gurufocus.comExelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026gurufocus.comMay 30seekingalpha.comHealthcare Realty Trust: Betting On Outpatient Demand Growth, Lower Operator Risk (Upgrade)seekingalpha.comMay 19